Detalhe da pesquisa
1.
Empagliflozin after Acute Myocardial Infarction.
N Engl J Med
; 390(16): 1455-1466, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587237
2.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
Circulation
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581389
3.
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation
; 2024 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583093
4.
Identification of three mechanistic pathways for iron-deficient heart failure.
Eur Heart J
; 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38733250
5.
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists.
Diabetologia
; 67(2): 246-262, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127122
6.
Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure.
Circulation
; 148(13): 1011-1022, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37621153
7.
Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.
Circulation
; 147(22): 1640-1653, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051919
8.
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
N Engl J Med
; 385(24): 2252-2263, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449181
9.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med
; 385(16): 1451-1461, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449189
10.
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease.
Am J Physiol Heart Circ Physiol
; 326(3): H670-H688, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133623
11.
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure.
Am Heart J
; 267: 52-61, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972677
12.
Metabolic dysfunction-associated steatotic liver disease and the heart.
Hepatology
; 2023 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147315
13.
High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial.
J Card Fail
; 30(4): 618-623, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38122924
14.
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis.
Diabetes Obes Metab
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558314
15.
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
Diabetes Obes Metab
; 26(1): 191-200, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37814928
16.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Ann Intern Med
; 176(12): 1606-1616, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048573
17.
Iron deficiency and cardiovascular disease.
Eur Heart J
; 44(1): 14-27, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282723
18.
The cardiovascular effects of novel weight loss therapies.
Eur Heart J
; 44(48): 5036-5048, 2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966486
19.
Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.
Eur Heart J
; 44(48): 5077-5091, 2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37632415
20.
Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials.
Eur Heart J
; 44(21): 1890-1909, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098746